Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radio therapeutic agent for Gastrin Releasing Peptide receptor positive tumors

被引：39
|
作者：
Chen, Jianqing [1 ]
Linder, Karen E. [1 ]
Cagnolini, Aldo [1 ]
Metcalfe, Edmund [1 ]
Raju, Natarajan [1 ]
Tweedle, Michael F. [1 ]
Swenson, Rolf E. [1 ]
机构：
[1] Bracco Res USA Inc, Princeton, NJ 08540 USA
来源：
APPLIED RADIATION AND ISOTOPES | 2008年 / 66卷 / 04期
关键词：
Lu-177-AMBA; bombesin; gastrin releasing peptide; targeted radiotherapy; radiolysis protection;
D O I：
10.1016/j.apradiso.2007.11.007
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
A robust formulation was developed for [Lu-177]Lu-AMBA (Lu-177-DO3A-CH2CO-G-[4-aminobenzoyl]-QWAVGHLM-NH2), a Bombesin-like agonist with high affinity for Gastrin Releasing Peptide (GRP) receptors. During optimization of labeling, the effect of several radiostabilizers was evaluated; a combination of selenomethionine and ascorbic acid showed superiority over other tested radiostabilizers. The resulting two-vial formulation maintains a radiochemical purity (RCP) of >90% for at least 2 days at room temperature. The method of stabilization should be useful for other methionine-containing peptide radiopharmaceuticals in diagnostic and therapeutic applications. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：497 / 505
页数：9
相关论文
共 47 条
  • [1] Formulation and in vitro metabolism studies with 177Lu-AMBA;: a radiotherapeutic compound that targets gastrin releasing peptide receptors
    Chen, J
    Nguyen, H
    Metcalfe, E
    Eaton, S
    Arunachalam, T
    Raju, N
    Cappelletti, E
    Lattuada, L
    Cagnolini, A
    Maddalena, M
    Lantry, LE
    Nunn, A
    Swenson, RE
    Tweedle, MF
    Linder, KE
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S281 - S281
  • [2] Preclinical pharmacokinetics evaluation of four novel 177Lu-labeled gastrin-releasing peptide receptor-targeted ligands: comparison with 177Lu-AMBA and 177Lu-RM2
    Wang, Lei
    Kuo, Hsiou-Ting
    Chapple, Devon
    Merkens, Helen
    Colpo, Nadine
    Ng, Pauline
    Lau, Wing Sum
    Wilson, Ryan
    Benard, Francois
    Lin, Kuo-Shyan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [3] 177Lu DOTATATE nanoparticles: A therapeutic option for peptide receptor radionuclide therapy
    Arora, Geetanjali
    Shukla, Jaya
    Ghosh, Sourabh
    Malhotra, Arun
    Bandohpadhyaya, Guru
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with 161Tb and 177Lu: A Comparative Study
    Holzleitner, Nadine
    Cwojdzinski, Tatjana
    Beck, Roswitha
    Urtz-Urban, Nicole
    Hillhouse, Colin C.
    V. Grundler, Pascal
    van der Meulen, Nicholas P.
    Talip, Zeynep
    Ramaekers, Stijn
    Van de Voorde, Michiel
    Ponsard, Bernard
    Casini, Angela
    Guenther, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (03) : 481 - 484
  • [5] Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy
    Zavvar, Taraneh Sadat
    Hoermann, Anton Amadeus
    Konijnenberg, Mark
    Kraihammer, Martin
    Mair, Christian
    Kronthaler, Ariane
    Joosten, Lieke
    Laverman, Peter
    Gruber, Leonhard
    di Santo, Gianpaolo
    Decristoforo, Clemens
    Virgolini, Irene
    von Guggenberg, Elisabeth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (04) : 1321 - 1331
  • [6] Efficacy of 177Lu Peptide Receptor Radionuclide Therapy for the Treatment of Neuroendocrine Tumors A Meta-analysis
    Saravana-Bawan, Bianka
    Bajwa, Amandeep
    Paterson, John
    McEwan, Alexander J. B.
    McMullen, Todd P. W.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 719 - 727
  • [7] Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26
    Baun, Christina
    Olsen, Birgitte Brinkmann
    Alves, Carla Maria Lourenco
    Ditzel, Henrik Jorn
    Terp, Mikkel
    Hildebrandt, Malene Grubbe
    Poulsen, Charlotte Aaberg
    Ge, Lorraine Gaenaelle
    Gammelsrod, Vigga Sand
    Orlova, Anna
    Dam, Johan Hygum
    Thisgaard, Helge
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 138
  • [8] First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
    Kurth, Jens
    Krause, Bernd Joachim
    Schwarzenboeck, Sarah M.
    Bergner, Carina
    Hakenberg, Oliver W.
    Heuschkel, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 123 - 135
  • [9] First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
    Jens Kurth
    Bernd Joachim Krause
    Sarah M. Schwarzenböck
    Carina Bergner
    Oliver W. Hakenberg
    Martin Heuschkel
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 123 - 135
  • [10] Safety and Dosimetry of [177Lu]Lu-DOTA-TATE in Adolescent Patients With Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors or Pheochromocytomas and Paragangliomas
    Giraudet, A.
    Handkiewicz-Junak, D.
    Hladun, R.
    Laetsch, T. W.
    Sorge, C.
    Sparks, R.
    Xu, L.
    Perraud, K.
    Kollar, G.
    Khanshan, F.
    Blumenstein, L.
    Brouri, F.
    Gaze, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S664 - S664
12345